학술논문
전자자료 공정이용 안내
우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.
공정이용 지침
- 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
- 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
- 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
- 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
- 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
- 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
- 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
- 상업적·영리적 목적으로 자료를 전송·복제·활용
- ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
- EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
- 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
- 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
- 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문'
에서 검색결과 6건 | 목록
1~20
Academic Journal
Haderk F; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA, USA.; Chou YT; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA, USA.; Cech L; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.; Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, CA, USA.; Fernández-Méndez C; Instituto de Investigaciones Biomédicas 'Alberto Sols', Consejo Superior de Investigaciones Científícas (CSIC) y Universidad Autónoma de Madrid (UAM), Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.; Yu J; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA.; Department of Biochemistry & Biophysics, University of California, San Francisco, San Francisco, CA, USA.; Department of Urology, University of California, San Francisco, San Francisco, CA, USA.; Olivas V; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA, USA.; Meraz IM; Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Barbosa Rabago D; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA, USA.; Kerr DL; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.; Gomez C; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.; Allegakoen DV; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA.; Guan J; Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, CA, USA.; Shah KN; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA.; Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, CA, USA.; Herrington KA; Center for Advanced Light Microscopy, University of California, San Francisco, San Francisco, CA, USA.; Gbenedio OM; Department of Anatomy, University of California, San Francisco, San Francisco, CA, USA.; Nanjo S; Division of Medical Oncology, Cancer Research Institute, Kanazawa University, Kanazawa, Japan.; Majidi M; Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Tamaki W; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.; Pourmoghadam YK; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.; Rotow JK; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; McCoach CE; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA.; Riess JW; University of California Davis Comprehensive Cancer Center, Sacramento, CA, USA.; Gutkind JS; Moores Cancer Center, University of California, San Diego, La Jolla, CA, USA.; Tang TT; Vivace Therapeutics, Inc., 1500 Fashion Island Blvd., Suite 102, San Mateo, CA, USA.; Post L; Vivace Therapeutics, Inc., 1500 Fashion Island Blvd., Suite 102, San Mateo, CA, USA.; Huang B; Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, CA, USA.; Department of Biochemistry & Biophysics, University of California, San Francisco, San Francisco, CA, USA.; Chan Zuckerberg Biohub, San Francisco, CA, USA.; Santisteban P; Instituto de Investigaciones Biomédicas 'Alberto Sols', Consejo Superior de Investigaciones Científícas (CSIC) y Universidad Autónoma de Madrid (UAM), Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.; Goodarzi H; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA.; Department of Biochemistry & Biophysics, University of California, San Francisco, San Francisco, CA, USA.; Department of Urology, University of California, San Francisco, San Francisco, CA, USA.; Bandyopadhyay S; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA.; Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, CA, USA.; Kuo CJ; Department of Medicine, Division of Hematology, Stanford University School of Medicine, Stanford, CA, USA.; Roose JP; Department of Anatomy, University of California, San Francisco, San Francisco, CA, USA.; Wu W; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.; Blakely CM; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA.; Roth JA; Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Bivona TG; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA. trever.bivona@ucsf.edu.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA. trever.bivona@ucsf.edu.; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA, USA. trever.bivona@ucsf.edu.
Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
Academic Journal
Leng K; Institute for Neurodegenerative Diseases, University of California, San Francisco, San Francisco, CA, USA. kun.leng@ucsf.edu.; Biomedical Sciences Graduate Program, University of California, San Francisco, San Francisco, CA, USA. kun.leng@ucsf.edu.; Medical Scientist Training Program, University of California, San Francisco, San Francisco, CA, USA. kun.leng@ucsf.edu.; Rooney B; Institute for Neurodegenerative Diseases, University of California, San Francisco, San Francisco, CA, USA.; McCarthy F; Chan Zuckerberg Biohub, San Francisco, CA, USA.; Xia W; Departments of Neurology and Pediatrics, School of Medicine, University of California, San Francisco, CA, USA.; Rose IVL; Institute for Neurodegenerative Diseases, University of California, San Francisco, San Francisco, CA, USA.; Neuroscience Graduate Program, University of California, San Francisco, San Francisco, CA, USA.; Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA.; Bax S; Chan Zuckerberg Biohub, San Francisco, CA, USA.; Chin M; Memory and Aging Center, Department of Neurology, University of California, San Francisco, San Francisco, CA, USA.; Small Molecule Discovery Center, Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, CA, USA.; Fathi S; Medical Scientist Training Program, University of California, San Francisco, San Francisco, CA, USA.; Herrington KA; Center for Advanced Microscopy, University of California, San Francisco, San Francisco, CA, USA.; Leonetti M; Chan Zuckerberg Biohub, San Francisco, CA, USA.; Kao A; Memory and Aging Center, Department of Neurology, University of California, San Francisco, San Francisco, CA, USA.; Fancy SPJ; Departments of Neurology and Pediatrics, School of Medicine, University of California, San Francisco, CA, USA.; Elias JE; Chan Zuckerberg Biohub, San Francisco, CA, USA.; Kampmann M; Institute for Neurodegenerative Diseases, University of California, San Francisco, San Francisco, CA, USA. martin.kampmann@ucsf.edu.; Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA. martin.kampmann@ucsf.edu.; Department of Biochemistry and Biophysics, University of California, San Francisco, San Francisco, CA, USA. martin.kampmann@ucsf.edu.
Publisher: BioMed Central Country of Publication: England NLM ID: 101222974 Publication Model: Electronic Cited Medium: Internet ISSN: 1742-2094 (Electronic) Linking ISSN: 17422094 NLM ISO Abbreviation: J Neuroinflammation Subsets: MEDLINE
Academic Journal
Kim M; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, CA, USA.; The J. David Gladstone Institute of Data Science and Biotechnology, San Francisco, CA, USA.; Quantitative Biosciences Institute, University of California, San Francisco, CA, USA.; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA, USA.; Park J; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA, USA.; Department of Medicine, University of California, San Diego, CA, USA.; Bouhaddou M; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, CA, USA.; The J. David Gladstone Institute of Data Science and Biotechnology, San Francisco, CA, USA.; Quantitative Biosciences Institute, University of California, San Francisco, CA, USA.; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA, USA.; Kim K; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, CA, USA.; The J. David Gladstone Institute of Data Science and Biotechnology, San Francisco, CA, USA.; Quantitative Biosciences Institute, University of California, San Francisco, CA, USA.; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA, USA.; Rojc A; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, CA, USA.; The J. David Gladstone Institute of Data Science and Biotechnology, San Francisco, CA, USA.; Quantitative Biosciences Institute, University of California, San Francisco, CA, USA.; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA, USA.; Modak M; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, CA, USA.; The J. David Gladstone Institute of Data Science and Biotechnology, San Francisco, CA, USA.; Quantitative Biosciences Institute, University of California, San Francisco, CA, USA.; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA, USA.; Soucheray M; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, CA, USA.; The J. David Gladstone Institute of Data Science and Biotechnology, San Francisco, CA, USA.; Quantitative Biosciences Institute, University of California, San Francisco, CA, USA.; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA, USA.; McGregor MJ; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, CA, USA.; The J. David Gladstone Institute of Data Science and Biotechnology, San Francisco, CA, USA.; Quantitative Biosciences Institute, University of California, San Francisco, CA, USA.; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA, USA.; O'Leary P; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA, USA.; Department of Medicine, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA.; Wolf D; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA, USA.; Department of Medicine, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA.; Stevenson E; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, CA, USA.; The J. David Gladstone Institute of Data Science and Biotechnology, San Francisco, CA, USA.; Quantitative Biosciences Institute, University of California, San Francisco, CA, USA.; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA, USA.; Foo TK; Department of Radiation Oncology, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.; Mitchell D; Quantitative Biosciences Institute, University of California, San Francisco, CA, USA.; Department of Medicine, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA.; Division of Hematology/Oncology, University of California, San Francisco, CA, USA.; Herrington KA; Department of Biochemistry and Biophysics, Center for Advanced Light Microscopy, University of California, San Francisco, CA, USA.; Muñoz DP; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA, USA.; Department of Medicine, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA.; Tutuncuoglu B; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, CA, USA.; The J. David Gladstone Institute of Data Science and Biotechnology, San Francisco, CA, USA.; Quantitative Biosciences Institute, University of California, San Francisco, CA, USA.; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA, USA.; Chen KH; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, CA, USA.; The J. David Gladstone Institute of Data Science and Biotechnology, San Francisco, CA, USA.; Quantitative Biosciences Institute, University of California, San Francisco, CA, USA.; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA, USA.; Zheng F; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA, USA.; Department of Medicine, University of California, San Diego, CA, USA.; Kreisberg JF; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA, USA.; Department of Medicine, University of California, San Diego, CA, USA.; Diolaiti ME; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA, USA.; Department of Medicine, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA.; Gordan JD; Quantitative Biosciences Institute, University of California, San Francisco, CA, USA.; Department of Medicine, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA.; Division of Hematology/Oncology, University of California, San Francisco, CA, USA.; Coppé JP; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA, USA.; Department of Medicine, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA.; Swaney DL; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, CA, USA.; The J. David Gladstone Institute of Data Science and Biotechnology, San Francisco, CA, USA.; Quantitative Biosciences Institute, University of California, San Francisco, CA, USA.; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA, USA.; Xia B; Department of Radiation Oncology, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.; van 't Veer L; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA, USA.; Department of Medicine, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA.; Ashworth A; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA, USA.; Department of Medicine, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA.; Ideker T; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA, USA.; Department of Medicine, University of California, San Diego, CA, USA.; Department of Bioengineering, University of California, San Diego, CA, USA.; Krogan NJ; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, CA, USA.; The J. David Gladstone Institute of Data Science and Biotechnology, San Francisco, CA, USA.; Quantitative Biosciences Institute, University of California, San Francisco, CA, USA.; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA, USA.
Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 0404511 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-9203 (Electronic) Linking ISSN: 00368075 NLM ISO Abbreviation: Science Subsets: MEDLINE
Academic Journal
Zheng F; Division of Genetics, Department of Medicine, University of California San Diego, La Jolla, CA 92093, USA.; Cancer Cell Map Initiative (CCMI), La Jolla, CA, USA.; Kelly MR; Division of Genetics, Department of Medicine, University of California San Diego, La Jolla, CA 92093, USA.; Cancer Cell Map Initiative (CCMI), La Jolla, CA, USA.; Ramms DJ; Cancer Cell Map Initiative (CCMI), La Jolla, CA, USA.; Moores Cancer Center, University of California San Diego, La Jolla, CA 92093, USA.; Department of Pharmacology, University of California San Diego, La Jolla, CA 92093, USA.; Heintschel ML; Department of Bioengineering, University of California San Diego, La Jolla, CA 92093, USA.; Tao K; Department of Biomedical Engineering, Oregon Health and Science University, Portland, OR 97239, USA.; Center for Spatial Systems Biomedicine, Oregon Health and Science University, Portland, OR 97201, USA.; Tutuncuoglu B; Cancer Cell Map Initiative (CCMI), La Jolla, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, CA 94158, USA.; J. David Gladstone Institutes, San Francisco, CA 94158, USA.; Quantitative Biosciences Institute, University of California, San Francisco, CA 94158, USA.; Lee JJ; Division of Genetics, Department of Medicine, University of California San Diego, La Jolla, CA 92093, USA.; Ono K; Division of Genetics, Department of Medicine, University of California San Diego, La Jolla, CA 92093, USA.; Foussard H; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, CA 94158, USA.; J. David Gladstone Institutes, San Francisco, CA 94158, USA.; Quantitative Biosciences Institute, University of California, San Francisco, CA 94158, USA.; Chen M; Division of Genetics, Department of Medicine, University of California San Diego, La Jolla, CA 92093, USA.; Herrington KA; Department of Biochemistry and Biophysics Center for Advanced Light Microscopy at UCSF, University of California, San Francisco, CA 94158, USA.; Silva E; Division of Genetics, Department of Medicine, University of California San Diego, La Jolla, CA 92093, USA.; Liu SN; Division of Genetics, Department of Medicine, University of California San Diego, La Jolla, CA 92093, USA.; Chen J; Division of Genetics, Department of Medicine, University of California San Diego, La Jolla, CA 92093, USA.; Churas C; Division of Genetics, Department of Medicine, University of California San Diego, La Jolla, CA 92093, USA.; Wilson N; Division of Genetics, Department of Medicine, University of California San Diego, La Jolla, CA 92093, USA.; Kratz A; Division of Genetics, Department of Medicine, University of California San Diego, La Jolla, CA 92093, USA.; Cancer Cell Map Initiative (CCMI), La Jolla, CA, USA.; Pillich RT; Division of Genetics, Department of Medicine, University of California San Diego, La Jolla, CA 92093, USA.; Cancer Cell Map Initiative (CCMI), La Jolla, CA, USA.; Patel DN; Division of Genetics, Department of Medicine, University of California San Diego, La Jolla, CA 92093, USA.; Cancer Cell Map Initiative (CCMI), La Jolla, CA, USA.; Park J; Division of Genetics, Department of Medicine, University of California San Diego, La Jolla, CA 92093, USA.; Cancer Cell Map Initiative (CCMI), La Jolla, CA, USA.; Kuenzi B; Division of Genetics, Department of Medicine, University of California San Diego, La Jolla, CA 92093, USA.; Cancer Cell Map Initiative (CCMI), La Jolla, CA, USA.; Yu MK; Division of Genetics, Department of Medicine, University of California San Diego, La Jolla, CA 92093, USA.; Licon K; Division of Genetics, Department of Medicine, University of California San Diego, La Jolla, CA 92093, USA.; Cancer Cell Map Initiative (CCMI), La Jolla, CA, USA.; Pratt D; Division of Genetics, Department of Medicine, University of California San Diego, La Jolla, CA 92093, USA.; Kreisberg JF; Division of Genetics, Department of Medicine, University of California San Diego, La Jolla, CA 92093, USA.; Cancer Cell Map Initiative (CCMI), La Jolla, CA, USA.; Kim M; Cancer Cell Map Initiative (CCMI), La Jolla, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, CA 94158, USA.; J. David Gladstone Institutes, San Francisco, CA 94158, USA.; Quantitative Biosciences Institute, University of California, San Francisco, CA 94158, USA.; Swaney DL; Cancer Cell Map Initiative (CCMI), La Jolla, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, CA 94158, USA.; J. David Gladstone Institutes, San Francisco, CA 94158, USA.; Quantitative Biosciences Institute, University of California, San Francisco, CA 94158, USA.; Nan X; Department of Biomedical Engineering, Oregon Health and Science University, Portland, OR 97239, USA.; Center for Spatial Systems Biomedicine, Oregon Health and Science University, Portland, OR 97201, USA.; Knight Cancer Early Detection Advanced Research Center, Oregon Health and Science University, Portland, OR 97201, USA.; Fraley SI; Department of Bioengineering, University of California San Diego, La Jolla, CA 92093, USA.; Gutkind JS; Cancer Cell Map Initiative (CCMI), La Jolla, CA, USA.; Moores Cancer Center, University of California San Diego, La Jolla, CA 92093, USA.; Department of Pharmacology, University of California San Diego, La Jolla, CA 92093, USA.; Krogan NJ; Cancer Cell Map Initiative (CCMI), La Jolla, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, CA 94158, USA.; J. David Gladstone Institutes, San Francisco, CA 94158, USA.; Quantitative Biosciences Institute, University of California, San Francisco, CA 94158, USA.; Ideker T; Division of Genetics, Department of Medicine, University of California San Diego, La Jolla, CA 92093, USA.; Cancer Cell Map Initiative (CCMI), La Jolla, CA, USA.; Moores Cancer Center, University of California San Diego, La Jolla, CA 92093, USA.; Department of Bioengineering, University of California San Diego, La Jolla, CA 92093, USA.
Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 0404511 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-9203 (Electronic) Linking ISSN: 00368075 NLM ISO Abbreviation: Science Subsets: MEDLINE
Academic Journal
Swaney DL; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; J. David Gladstone Institutes, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA.; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA.; Ramms DJ; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA.; Department of Pharmacology, University of California San Diego, La Jolla, CA.; Moores Cancer Center, University of California San Diego, La Jolla, CA.; Wang Z; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA.; Moores Cancer Center, University of California San Diego, La Jolla, CA.; Park J; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA.; Division of Genetics, Department of Medicine, University of California San Diego, La Jolla, CA.; Goto Y; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA.; Moores Cancer Center, University of California San Diego, La Jolla, CA.; Soucheray M; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; J. David Gladstone Institutes, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA.; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA.; Bhola N; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA.; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA.; Kim K; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; J. David Gladstone Institutes, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA.; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA.; Zheng F; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA.; Division of Genetics, Department of Medicine, University of California San Diego, La Jolla, CA.; Zeng Y; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA.; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA.; McGregor M; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; J. David Gladstone Institutes, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA.; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA.; Herrington KA; Department of Biochemistry and Biophysics Center for Advanced Light Microscopy at UCSF, University of California San Francisco, San Francisco, CA, USA.; O'Keefe R; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA.; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA.; Jin N; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA.; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA.; VanLandingham NK; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA.; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA.; Foussard H; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; J. David Gladstone Institutes, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA.; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA.; Von Dollen J; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; J. David Gladstone Institutes, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA.; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA.; Bouhaddou M; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; J. David Gladstone Institutes, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA.; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA.; Jimenez-Morales D; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; J. David Gladstone Institutes, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA.; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA.; Obernier K; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; J. David Gladstone Institutes, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA.; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA.; Kreisberg JF; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA.; Division of Genetics, Department of Medicine, University of California San Diego, La Jolla, CA.; Kim M; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; J. David Gladstone Institutes, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA.; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA.; Johnson DE; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA.; Jura N; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA.; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA.; Cardiovascular Research Institute, University of California San Francisco, San Francisco, CA, USA.; Grandis JR; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA.; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA.; Gutkind JS; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA.; Department of Pharmacology, University of California San Diego, La Jolla, CA.; Moores Cancer Center, University of California San Diego, La Jolla, CA.; Ideker T; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA.; Division of Genetics, Department of Medicine, University of California San Diego, La Jolla, CA.; Department of Bioengineering, University of California San Diego, La Jolla, CA, USA.; Department of Computer Science, University of California San Diego, La Jolla, CA, USA.; Krogan NJ; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; J. David Gladstone Institutes, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA.; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA.
Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 0404511 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-9203 (Electronic) Linking ISSN: 00368075 NLM ISO Abbreviation: Science Subsets: MEDLINE
Academic Journal
Herrington, Kari A; Trinh, Andrew L; Dang, Carolyn; O’Shaughnessy, Ellen; Hahn, Klaus M; Gratton, Enrico; Digman, Michelle A; Sütterlin, Christine
Mol Biol Cell
Molecular Biology of the Cell, vol 28, iss 15
Molecular Biology of the Cell, vol 28, iss 15
검색 결과 제한하기
제한된 항목
[AR] Herrington, Kari A
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어